GlassScriptPhysician profile
Darren M Traub
NPI 1679602288
$48,664.92
in general payments reported to CMS, 2019-2025
21 companies · $9,897 in 2025
The $9,897 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,107 · 2020: $9,047 · 2021: $1,052 · 2022: $5,750 · 2023: $5,670 · 2024: $15K · 2025: $9,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $9,622 · Food and Beverage: $6,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,400.00 |
| Travel and Lodging | $9,621.65 |
| Food and Beverage | $6,688.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,828.50 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan, Linq II |
| Philips North America LLC | $6,033.68 | 2020-2025 | Lm Undivided, Labosys |
| Abbott Laboratories | $5,724.74 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Boston Scientific Corporation | $3,445.20 | 2019-2025 | General - Therapies, Watchman Access System, Rhythmia Mapping System |
| Medtronic Vascular, INC. | $3,155.97 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,539.75 | 2019-2020 | |
| Atricure, INC. | $1,170.22 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $960.70 | 2024 | Sensis |
| Edwards Lifesciences Corporation | $689.37 | 2019-2025 | Sapien 3 Ultra Resilia |
| Endologix LLC | $173.61 | 2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Impulse Dynamics (USA) INC. | $157.03 | 2024 | Optimizer |
| Biosense Webster, INC. | $155.88 | 2019-2023 | Carto 3 |
| Zoll Respicardia, INC. | $149.92 | 2025 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Inspire Medical Systems, INC. | $124.80 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $123.95 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Terumo Medical Corporation | $39.15 | 2022-2024 | Progreat, Glidewire |
| Biotronik INC. | $28.17 | 2025 | Acticor 7 Vr-T Dx |
| Ge Healthcare | $26.37 | 2022 | |
| Cook Medical LLC | $12.91 | 2023 | Zilver Ptx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Traub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.